CHNA

Loncar China BioPharma ETF

Down$21.95
$-0.14
(-0.63%)
As of 1:00:00 AM EDT | 2/15/19  |  Market Closed

CHNA Trading Data

Open

$21.95

Low Price

$21.95

High Price

$21.95

Previous Last Price

$22.09

Bid Size

$0 X 0

Ask Size

$0 X 0

CHNA Portfolio Data

AUM

$2,201,000

Shares

100

PE Ratio

17.91

Price / Book Ratio

2.42

Expense Ratio

0.79

Net Asset Value

$22.01

Volume

Volume

1,000

Avg. Volume (YDT)

1,381

Dollar Volume

$0

Weekly Avg. Volume

600

Monthly Avg. Volume

1,220

Quarterly Avg. Volume

2,931

CHNA Fund Description

The China BioPharma ETF offers exposure to a basket of companies powering China's biopharmaceutical industry. With a long-term goal of steering its economy towards innovation, China aims be a global leader in medicine. CHNA seeks to invest in this opportunity with the convenience of one security that trades in the United States. It invests in pharmaceutical companies, biotech companies,drug manufacturers, diagnostics companies, wholesalers, distributors, and service providers that have a strategic focus in growing China's drug industry.

CHNA Chart

CHNA Summary

Fund Family

Exchange Traded Concepts

Tracks This Index

Loncar China BioPharma ETF

Inception Date

2018-08-14

Asset Class

Equity

Asset Class Size

CHNA Classification

Region (General)

Asia-Pacific

Region (Specific)

China

Sector

Equity Index

Leveraged Family

CHNA Holdings

Top 10 Holdings

Loncar CHINA BIOPHARMA ETF (CHNA)
0%
%
%
%
%
%
%
%
%
%

Total CHNA Holdings

Total Holdings: 1

Loncar CHINA BIOPHARMA ETF (CHNA)
0%

CHNA Technicals

Alpha

0

Beta

1.32

Leverage

Long

Standard Deviation

0

CHNA Dividends

Dividend Date

Latest Dividend

Annual Dividend

0

Annual Dividend Rate

0

Annual Dividend Yield

1.0E-5

CHNA Performance

YTD Return

14.44%

1 Year Return

-7.77%

3 Year Return

0%

5 Year Return

0%

10 Year Return

-12.58%

CHNA Related Articles